Cargando…
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug interactions with emerging COVID‐19 treatments. Common u...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660727/ https://www.ncbi.nlm.nih.gov/pubmed/32515253 http://dx.doi.org/10.1161/JAHA.120.017529 |